Video: 2020 European Drug Report: Key Issues


High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the (EMCDDA in its European Drug Report 2020: Trends and Developments. In its latest annual review — marking 25 years of monitoring — the agency describes the drug situation at the end of 2019, along with recent changes brought by the COVID-19 pandemic in early 2020.

This video presents the key issues of the report.